Mirae Asset Global Investments
AMLX icon

Mirae Asset Global Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History

Mirae Asset Global Investments’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.3K Sell
4,973
-755
-13% -$11.7K ﹤0.01% 1257
2026
Q1 		$79.6K Buy
5,728
+391
+7% +$5.5K ﹤0.01% 1216
2025
Q4 		$64.5K Buy
5,337
+1,890
+55% +$25.7K ﹤0.01% 1343
2025
Q3 		$46.8K Buy
3,447
+4
+0.1% +$38 ﹤0.01% 1358
2025
Q2 		$22.1K Buy
3,443
+513
+18% +$2.5K ﹤0.01% 1386
2025
Q1 		$10.7K Buy
2,930
+646
+28% +$2.3K ﹤0.01% 1461
2024
Q4 		$8.84K Sell
2,284
-178
-7% -$838 ﹤0.01% 1528
2024
Q3 		$7.58K Buy
2,462
+432
+21% +$971 ﹤0.01% 1507
2024
Q2 		$3.92K Sell
2,030
-21,812
-91% -$42.3K ﹤0.01% 1496
2024
Q1 		$672K Sell
23,842
-515
-2% -$6.74K ﹤0.01% 1757
2023
Q4 		$359K Buy
24,357
+103
+0.4% +$1.58K ﹤0.01% 2119
2023
Q3 		$444K Buy
24,254
+905
+4% +$19.1K ﹤0.01% 1941
2023
Q2 		$504K Sell
23,349
-115
-0.5% -$3.11K ﹤0.01% 1945
2023
Q1 		$688K Sell
23,464
-43
-0.2% -$1.49K ﹤0.01% 1751
2022
Q4 		$869K Buy
23,507
+8,622
+58% +$306K ﹤0.01% 1576
2022
Q3 		$419K Buy
+14,885
New +$371K ﹤0.01% 1979

Other funds holding AMLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mirae Asset Global Investments's AMLX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Amylyx Pharmaceuticals (AMLX) stake by 13% in Q2 2026, selling an estimated $11.7K and leaving 4,973 shares worth $89.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Mirae Asset Global Investments first reported a position in AMLX in Q3 2022 and has held it in 16 quarters since. The position peaked at $869K in Q4 2022. 52 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Mirae Asset Global Investments held 4,973 shares of Amylyx Pharmaceuticals worth $89.3K as of Q2 2026.
  • Mirae Asset Global Investments sold 755 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $11.7K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1257 holding.
  • Mirae Asset Global Investments first reported a position in Amylyx Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Amylyx Pharmaceuticals position peaked at $869K in Q4 2022.
  • 52 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.